Idibell

Here comes Sinergia, the festival of research and innovation in health of L’Hospitalet

Saturday, November 16, from 10 a.m. to 2 p.m., open day at the facilities of the Duran i Reynals Hospital. This event wants to showcase the responsible and innovative research carried out at the Bellvitge Biomedical Pole

Here comes Sinergia, the festival of research and innovation in health of L’Hospitalet Read More »

Innovation for value analyzes the use of big data and the new power it gives to patients

The conference on health innovation Innovation for value, held on November 8 in Barcelona, ​​has analyzed the opportunities offered by technological advances in the field of health. The conference, organized by the Bellvitge Biomedical Research Institute (IDIBELL) and the Platform for Innovation in Medical and Health Technologies (ITEMAS), has been attended by some of the

Innovation for value analyzes the use of big data and the new power it gives to patients Read More »

Successful informative session on U.S. Non-dilutive funding at IDIBELL

The “U.S. Federal sources for health Projects” informative session was successfully held at IDIBELL last October 21st. Jointly co-organized with AGAUR, the Agency for Management of University and Research Grants, the session featured two seminars on U.S. funding sources for Health Projects, that were delivered by Dr. Ana Turchetti-Maia, Director of Business Development at Freemind

Successful informative session on U.S. Non-dilutive funding at IDIBELL Read More »

The consul general of France in Barcelona visits IDIBELL

The consul general of France in Barcelona, Cyril Piquemal, visited IDIBELL on October 23rd in order to get to know the institute and promote collaborations and synergies with French institutions. The visit took place as part of the efforts made by the French consulate to strengthen the interaction between research centers in Catalonia and France.

The consul general of France in Barcelona visits IDIBELL Read More »

Humanizing worms makes them sensitive to a cancer drug and identifies weak points of tumor cells

At first glance, a one-millimeter worm that needs to be observed with a magnifying glass does not resemble a human being at all. However, the nematode Caenorhabditis elegans, an animal model widely used in biomedical research by hundreds of laboratories around the world, has approximately the same number of genes that humans have, about 20,000.

Humanizing worms makes them sensitive to a cancer drug and identifies weak points of tumor cells Read More »

IDIBELL and Sant Joan de Déu join efforts to create the first animal model of Sturge-Weber Syndrome

The project is led by Dr. Eulàlia Baselga, Area of Dermatology of the Hospital Sant Joan de Déu Barcelona, and Dr. Mariona Graupera, Bellvitge Biomedical Research Institute (IDIBELL). Its main objective is to identify a treatment aimed at reversing or improving the vascular alterations produced by the R183Q mutation in the GNAQ gene that leads to Sturge-Weber Syndrome.

IDIBELL and Sant Joan de Déu join efforts to create the first animal model of Sturge-Weber Syndrome Read More »

Scroll to Top